Cargando…
Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
BACKGROUND: 1,3-beta-D-glucan (BG) is a ubiquitous cell wall component of gut micro-organisms. We hypothesized that the serum levels of BG could reflect active intestinal inflammation in patients with inflammatory bowel disease. AIM: To determine whether the serum BG concentrations correlate with in...
Autores principales: | Farias e Silva, Katia, Nanini, Hayandra F, Cascabulho, Cynthia Machado, Rosas, Siane L B, Santana, Patricia T, Carneiro, Antonio José de V, Anaissie, Elias, Nucci, Marcio, de Souza, Heitor Siffert Pereira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941859/ https://www.ncbi.nlm.nih.gov/pubmed/33727775 http://dx.doi.org/10.3748/wjg.v27.i9.866 |
Ejemplares similares
-
Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets
por: Nanini, Hayandra Ferreira, et al.
Publicado: (2018) -
P2X7 Receptor Modulation of the Gut Microbiota and the Inflammasome Determines the Severity of Toxoplasma gondii-Induced Ileitis
por: Moreira-Souza, Aline Cristina Abreu, et al.
Publicado: (2023) -
Infections After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
por: Nucci, Marcio, et al.
Publicado: (2014) -
Prevention of Infections in Patients with Hematological Malignancies
por: Nucci, Marcio, et al.
Publicado: (2017) -
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
por: Santana, Patricia Teixeira, et al.
Publicado: (2022)